ZYM-201 sodium succinate ameliorates streptozotocin-induced hyperlipidemic conditions

Planta Medica

Volumn 78, Issue 1, 2012, Pages 12-17

  Choi, Jongwon ^a   Kim, Mi Yeon ^b   Cha, Bae Cheon ^c   Yoo, Eun Sook ^d   Yoon, Keejung ^e   Lee, Jaehwi ^f   Rho, Ho Sik ^g   Kim, Sun Young ^h   Cho, Jae Youl ^e  

^a Kyungsung University   (South Korea)

^b Soongsil University   (South Korea)

^c Sangji University   (South Korea)

^d Jeju National University School of Medicine   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Chung Ang University   (South Korea)

^g AmorePacific Corporation   (South Korea)

^h Hongcheon Institute of Medicinal Herbs   (South Korea)

Author keywords

antihyperlipidemic activity; diabetes; Rosaceae; Sanguisorba officinalis L.; triterpenoid glycoside; ZYM 201 sodium succinate

Indexed keywords

ANTILIPEMIC AGENT; CHOLESTEROL; FENOFIBRATE; HIGH DENSITY LIPOPROTEIN; HYDROXYL RADICAL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE; LIPID PEROXIDE; LOW DENSITY LIPOPROTEIN; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRIACYLGLYCEROL; TRIACYLGLYCEROL LIPASE; TRITERPENOID; UNCLASSIFIED DRUG; VERY LOW DENSITY LIPOPROTEIN; ZYM 201;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG DOSE COMPARISON; ENZYME ACTIVATION; ENZYME ACTIVITY; HYPERLIPIDEMIA; LIPID PEROXIDATION; LIPOPROTEIN BLOOD LEVEL; MALE; NONHUMAN; OXIDATIVE STRESS; RAT; STREPTOZOCIN DIABETES; TRIACYLGLYCEROL BLOOD LEVEL; UPREGULATION;

ANIMALS; ANTIOXIDANTS; DIABETES COMPLICATIONS; DRUGS, CHINESE HERBAL; GLYCOSIDES; HYDROXYL RADICAL; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPID PEROXIDATION; LIPIDS; MALE; PHYTOTHERAPY; RATS; RATS, SPRAGUE-DAWLEY; SANGUISORBA; STREPTOZOCIN; SUPEROXIDE DISMUTASE; TRITERPENES;

RATTUS; ROSACEAE; SANGUISORBA OFFICINALIS;

EID: 84855670013     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0031-1280219     Document Type: Article

References (35)

1. Hvidtfeldt U A., Frederiksen M E., Thygesen L C., Kamper-Jorgensen M, Becker U, Gronbaek M. Incidence of cardiovascular and cerebrovascular disease in Danish men and women with a prolonged heavy alcohol intake. Alcohol Clin Exp Res 2008 32 1920-1924
2. Connor W E., Connor S L. Diet, atherosclerosis, and fish oil. Adv Intern Med 1990 35 139-171
3. Taniguchi M, Yasutake A, Takedomi K, Inoue K. Effects of N-nitrosodimethylamine (NDMA) on the oxidative status of rat liver. Arch Toxicol 1999 73 141-146 (Pubitemid 29279499)
4. Gomez J, Caro P, Naudi A, Portero-Otin M, Pamplona R, Barja G. Effect of 8.5% and 25% caloric restriction on mitochondrial free radical production and oxidative stress in rat liver. Biogerontology 2007 8 555-566 (Pubitemid 47365343)
5. Matsuo M, Ito F, Konto A, Aketa M, Tomoi M, Shimomura K. Effect of FR145237, a novel ACAT inhibitor, on atherogenesis in cholesterol-fed and WHHL rabbits. Evidence for a direct effect on the arterial wall. Biochim Biophys Acta 1995 1259 254-260 (Pubitemid 26018516)
6. Leitersdorf E. Selective cholesterol absorption inhibition: a novel strategy in lipid-lowering management. Int J Clin Pract 2002 56 116-119 (Pubitemid 34232985)
7. Cho J Y., Yoo E S., Cha B C., Park H J., Rhee M H., Han Y N. The inhibitory effect of triterpenoid glycosides originating from Sanguisorba officinalis on tissue factor activity and the production of TNF-alpha. Planta Med 2006 72 1279-1284
8. Asao Y, Morikawa T, Xie Y, Okamoto M, Hamao M, Matsuda H, Muraoka O, Yuan D, Yoshikawa M. Structures of acetylated oleanane-type triterpene saponins, rarasaponins IV, V, and VI, and anti-hyperlipidemic constituents from the pericarps of Sapindus rarak. Chem Pharm Bull (Tokyo) 2009 57 198-203
9. Lee K T., Sohn I C., Kim D H., Choi J W., Kwon S H., Park H J. Hypoglycemic and hypolipidemic effects of tectorigenin and kaikasaponin III in the streptozotocin-lnduced diabetic rat and their antioxidant activity in vitro. Arch Pharm Res 2000 23 461-466
10. Maiti R, Das U K., Ghosh D. Attenuation of hyperglycemia and hyperlipidemia in streptozotocin-induced diabetic rats by aqueous extract of seed of Tamarindus indica. Biol Pharm Bull 2005 28 1172-1176 (Pubitemid 41327580)
11. Ravi K, Rajasekaran S, Subramanian S. Antihyperlipidemic effect of Eugenia jambolana seed kernel on streptozotocin-induced diabetes in rats. Food Chem Toxicol 2005 43 1433-1439 (Pubitemid 40894640)
12. Kim H J., Chae I G., Lee S G., Jeong H J., Lee E J., Lee I S. Effects of fermented red ginseng extracts on hyperglycemia in streptozotocin-induced diabetic rats. J Ginseng Res 2010 34 369-375
13. Park Y S., Choi J, Kim K Y., Lim J S., Yoon S, Yang Y. A novel PPAR gamma agonist, SP1818, shows different coactivator profile with rosiglitazone. Biomol Ther 2010 18 77-82
14. Nikkari T, Schreibman P H., Ahrens jr. E H. In vivo studies of sterol and squalene secretion by human skin. J Lipid Res 1974 15 563-573
15. Min S W., Jung S H., Cho K H., Kim D H. Antihyperlipidemic effects of red ginseng, Crataegii fructus and their main constituents ginsenoside Rg3 and ursolic acid in mice. Biomol Ther 2008 16 364-369
16. Takahashi T, Hirano T, Okada K, Adachi M. Apolipoprotein CIII deficiency prevents the development of hypertriglyceridemia in streptozotocin-induced diabetic mice. Metabolism 2003 52 1354-1359 (Pubitemid 37351105)
17. Sagone jr. A L., Decker M A., Wells R M., Democko C. A new method for the detection of hydroxyl radical production by phagocytic cells. Biochim Biophys Acta 1980 628 90-97
18. Giada F, Baldo-Enzi G, Balocchi M R., Zuliani G, Baroni L, Fellin R. Heparin-released plasma lipase activities, lipoprotein and apoprotein levels in young adult cyclists and sedentary men. Int J Sports Med 1988 9 270-274
19. Fraga C G., Leibovitz B E., Tappel A L. Lipid peroxidation measured as thiobarbituric acid-reactive substances in tissue slices: characterization and comparison with homogenates and microsomes. Free Radic Biol Med 1988 4 155-161 (Pubitemid 18052530)
20. Wahlund G, Marklund S L., Sjoquist P O. Extracellular-superoxide dismutase type C (EC-SOD C) reduces myocardial damage in rats subjected to coronary occlusion and 24 hours of reperfusion. Free Radic Res Commun 1992 17 41-47
21. Ametaj B N., Bobe G, Lu Y, Young J W., Beitz D C. Effect of sample preparation, length of time, and sample size on quantification of total lipids from bovine liver. J Agric Food Chem 2003 51 2105-2110
22. Bradford M M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 248-254
23. Kwak Y S., Kyung J S., Kim J S., Cho J Y., Rhee M H. Anti-hyperlipidemic effects of red ginseng acidic polysaccharide from Korean red ginseng. Biol Pharm Bull 2010 33 468-472
24. Lee H S., Woo S J., Ku S K. Hypolipidemic and hepatoprotective effects of Picrorrhiza rhizoma in high fat diet supplied mice. A prevention study. Biomol Ther 2008 16 46-53
25. Yua H D., Kim S J., Quan H Y., Huang B, Chung S H. Ginseng leaf extract prevents high fat diet-induced hyperglycemia and hyperlipidemia through AMPK activation. J Ginseng Res 2010 34 369-375
26. Nakashima A, Nakashima R, Ito T, Masaki T, Yorioka N. HMG-CoA reductase inhibitors prevent bone loss in patients with type 2 diabetes mellitus. Diabet Med 2004 21 1020-1024 (Pubitemid 39215323)
27. Wang C S., Weingand K W., Anthony M S. Effect of atherogenic diet on lipoprotein lipase activity in cynomolgus monkeys. Atherosclerosis 1987 67 173-180 (Pubitemid 17132992)
28. Afrose S, Hossain M S., Maki T, Tsujii H. Effects of karaya saponin and Rhodobacter capsulatus on yolk cholesterol in laying hens. Br Poult Sci 2010 51 409-418
29. Hu X Q., Wang Y M., Wang J F., Xue Y, Li Z J., Nagao K, Yanagita T, Xue C H. Dietary saponins of sea cucumber alleviate orotic acid-induced fatty liver in rats via PPARalpha and SREBP-1c signaling. Lipids Health Dis 2010 9 25
30. Popovich D G., Li L, Zhang W. Bitter melon (Momordica charantia) triterpenoid extract reduces preadipocyte viability, lipid accumulation and adiponectin expression in 3T3-L1 cells. Food Chem Toxicol 2010 48 1619-1626
31. Collino M, Patel N S., Thiemermann C. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury. Ther Adv Cardiovasc Dis 2008 2 179-197 (Pubitemid 351859071)
32. Noh J R., Kim Y H., Gang G T., Yang K J., Kim S K., Ryu S Y., Kim Y S., Lee C H., Lee H S. Preventative effects of Platycodon grandiflorum treatment on hepatic steatosis in high fat diet-fed C57BL/6 mice. Biol Pharm Bull 2010 33 450-454
33. Cohn J S., Kamili A, Wat E, Chung R W., Tandy S. Reduction in intestinal cholesterol absorption by various food components: mechanisms and implications. Atheroscler Suppl 2010 11 45-48
34. Stevens M J. Oxidative-nitrosative stress as a contributing factor to cardiovascular disease in subjects with diabetes. Curr Vasc Pharmacol 2005 3 253-266 (Pubitemid 40933048)
35. Zaware P, Shah S R., Pingali H, Makadia P, Thube B, Pola S, Patel D, Priyadarshini P, Suthar D, Shah M, Jamili J, Sairam K V., Giri S, Patel L, Patel H, Sudani H, Patel H, Jain M, Patel P, Bahekar R. Modulation of PPAR subtype selectivity. Part 2: Transforming PPARalpha/gamma dual agonist into alpha selective PPAR agonist through bioisosteric modification. Bioorg Med Chem Lett 2011 21 628-632